Update shared on 10 Dec 2025
Fair value Increased 2.50%Analysts have modestly raised their price target on Patria Investments to approximately $16.57 from $16.17, citing higher projected revenue growth, a sharply improved profit margin profile, a slightly lower discount rate, and a normalization of future valuation multiples.
Valuation Changes
- Fair Value Estimate has risen slightly from $16.17 to $16.57 per share, reflecting a modest upward revision in intrinsic valuation.
- Discount Rate has edged down marginally from 8.34% to 8.28%, indicating a slightly lower perceived risk profile or cost of capital.
- Revenue Growth has increased from about 9.51% to 11.55%, suggesting higher expectations for top line expansion.
- Net Profit Margin has risen significantly from roughly 9.89% to 36.70%, pointing to a much stronger anticipated profitability profile.
- Future P/E Multiple has fallen sharply from approximately 71.3x to 14.2x, implying a more conservative valuation framework for forward earnings.
Have other thoughts on Patria Investments?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.